Compendia Bioscience
Curated by SignalGenomic data and analysis tools
Overview
Compendia Bioscience specializes in collecting, analyzing, and integrating cancer genomics data for drug development, diagnostics and personalized medicine. Data collection process includes direct correspondence with study authors to gather all available sample facts, often beyond those presented in the original publication. Its main products are Oncomine, aggregates and analyze the oncology data and provide practical, actionable views on the data and results. Oncopredictor, a biomarker discovery platform, performs comprehensive analyses to identify genomic biomarkers of in vitro drug response and importantly, predicts patient populations most likely to benefit from the drug, oncology companion diagnostics platform, Oncoscore, leverages the molecular diversity of cancer to provide deep molecular sub-typing of cancer patients. On October 8, 2012 the company was acquired by Life Technologies, which is a part of Thermo Fisher Scientific.
Key facts
- Founded
- 2006
- Headquarters
- Ann Arbor, United States
- Stage
- Sign up to view
- Industry
- Health Technology
Contact
- Primary office
- Sign up to view